XML 337 R97.htm IDEA: XBRL DOCUMENT v3.23.4
FAIR VALUE OF FINANCIAL INSTRUMENTS AND FINANCIAL RISK FACTORS - Narrative (Details)
$ in Thousands, $ in Thousands
13 Months Ended
Sep. 30, 2023
CAD ($)
May 25, 2023
USD ($)
tranches
Aug. 31, 2022
CAD ($)
Aug. 31, 2021
CAD ($)
Disclosure of detailed information about financial instruments [line items]        
Liabilities $ 26,832   $ 69,049  
Maximum exposure to credit risk 90,351   171,799  
Cash 33,864   68,515 $ 55,365
Working capital 133,545   166,338  
Contractual capital commitments $ 850      
Change In Benchmark Interest Rates 1.00%      
Long-term borrowings        
Disclosure of detailed information about financial instruments [line items]        
Fair value of long-term debt $ 155   $ 235  
Laurentian | Contingent consideration        
Disclosure of detailed information about financial instruments [line items]        
Liabilities $ 49      
Phylos Bioscience Inc. ("Phylos")        
Disclosure of detailed information about financial instruments [line items]        
Secured convertible loan advanced   $ 8,000    
Number of remaining tranches, secured convertible loan | tranches   2    
Second and third | Phylos Bioscience Inc. ("Phylos")        
Disclosure of detailed information about financial instruments [line items]        
Secured convertible loan advanced   $ 4,750